Company Overview and News

China stocks extend losses on growth concerns, trade war worries

2018-09-04 thehindubusinessline
Manufacturing activity took a hit from weak orders in August, surveys showed, a sign firms are feeling the pinch from an intensifying trade war between the United States and China that could derail global growth.

Hong Kong stocks fall, energy shares weigh

2018-07-17 theedgemarkets
SHANGHAI (July 17): Hong Kong stocks ended lower on Tuesday, dragged by energy firms following a sharp decline in crude oil prices.
1336 GGDVF GGDVY 0270 CEO 1044

China and Hong Kong stocks slide, with Shanghai Composite Index declining to two-year low

2018-06-25 scmp
Cut in reserve requirement ratio announced on Sunday by People’s Bank of China ‘doesn’t signal a shift in monetary policies’, as the central bank ‘continues to focus on deleveraging’, say analysts

China, Hong Kong stocks wobble on trade war fears

2018-06-21 thehindubusinessline
China and Hong Kong shares reversed earlier gains to slide on Thursday, as concerns over a trade spat between China and the United States weighed on sentiment.
1336 CGHLY JINDALSAW 0914 500378 CGHOF CEO 1088 0384

Chinese tech stocks surge after Nasdaq closes at all-time high

2018-06-05 scmp
Mainland Chinese and Hong Kong stocks closed higher on Tuesday, bolstered by the technology sector, after Apple, Amazon and Microsoft touched fresh records helping to push the Nasdaq to an all-time closing high overnight.
1336 2628 0700 SOTGY LFC 2382 SNPTF AACAY AACAF

Moody’s raises view on China life insurers as regulatory tightening cuts risk

2018-06-05 scmp
A government crackdown on the practice of issuing short-term policies for financial gain is improving the industry’s creditworthiness, the agency says
1336 2628 CHIB 2601 LFC CKGOY

China’s high-flying big-cap stocks hit as PBOC raises borrowing costs

2018-03-22 scmp
The SSE 50 Index is set for the steepest decline in three weeks after China’s central bank raised 7-day reverse repo rates

China, Hong Kong stocks rise as developers rally on stellar profits

2018-03-21 thehindubusinessline
Stocks in China and Hong Kong rallied on Wednesday, led by real estate firms, after developers posted stellar profits for 2017.
CRBJY 1336 1109 CRBJF 2007

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...